Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA3 | ISIN: US56270V2051 | Ticker-Symbol:
NASDAQ
27.06.25 | 21:34
1,680 US-Dollar
-6,15 % -0,110
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MANGOCEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MANGOCEUTICALS INC 5-Tage-Chart

Aktuelle News zur MANGOCEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.06.Mangoceuticals files $150M mixed securities shelf1
10.06.MANGOCEUTICALS, INC. - 8-K, Current Report1
30.05.Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders1
30.05.MANGOCEUTICALS, INC. - S-1, General form for registration of securities1
27.05.Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu95Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and...
► Artikel lesen
23.05.MANGOCEUTICALS, INC. - 8-K, Current Report4
MANGOCEUTICALS Aktie jetzt für 0€ handeln
15.05.MANGOCEUTICALS, INC. - 10-Q, Quarterly Report-
06.05.MANGOCEUTICALS, INC. - 8-K, Current Report5
26.04.ArcStone US Corp.: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into th1.067New York, New York and Dallas, Texas--(Newsfile Corp. - April 26, 2025) - ArcStone Securities and Investments Corp. ("ArcStone"), a cross-border financial services firm, is pleased to announce its role...
► Artikel lesen
25.04.Mangoceuticals acquires Smokeless Tech intellectual property2
25.04.Mangoceuticals, Inc.: Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch ...280DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) ("Mangoceuticals" or "MGRX"), a company focused on developing, marketing, and selling a variety of health and wellness...
► Artikel lesen
25.04.MANGOCEUTICALS, INC. - 8-K, Current Report2
22.04.CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape332DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when...
► Artikel lesen
17.04.MANGOCEUTICALS, INC. - 8-K, Current Report1
08.04.MANGOCEUTICALS, INC. - 8-K, Current Report1
01.04.MANGOCEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans1
28.03.MANGOCEUTICALS, INC. - 8-K, Current Report1
25.03.Mangoceuticals, Inc.: Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol in the USA and Canada196Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals...
► Artikel lesen
20.03.MANGOCEUTICALS, INC. - 10-K, Annual Report1
19.03.MANGOCEUTICALS, INC. - 8-K, Current Report2
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1